Clinical Trial Update: The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral cyclosporine and omeprazole for insulin independence in recent-onset Type 1 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Perle Bioscience, Inc. | Conditions: Type 1 Diabetes | Phase 3 | Status: WITHDRAWN